CDC Identifies Contamination in More Medical Products From New England Compounding Center
The CDC has identified additional microbial contamination in unopened vials of betamethasone, cardioplegia and triamcinolone solutions that were distributed and recalled from NECC.
Clinicians should continue to report infections related to NECC products to FDA's MedWatch and state health departments.
Related Articles on ASC Medical Supplies:
Access MediQuip Names Patrick McCarthy Chief Network Development Officer
Volcano Corp. to Acquire Crux Biomedical
FDA Enters Partnership to Help Increase Access to New Medical Devices
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
New from Becker's ASC Review
3 Things to Know About Anesthesia and Narrow NetworksRead Now
- 4 Tips for ASCs to Select a Business Analytics System and Streamline Collections
- Business Advisor Relationships: 4 Common Mistakes ASCs Make
- Corporate Compliance Committees: Why Healthcare Facilities Need One
- PriorityOne Launches New Corporate Identity, Moves to Bigger Office
- Online Preoperative Screening Advantages: Q&A With Ambulatory Surgical Center of Stevens Point's Becky Ziegler-Otis